Education
About Us
Working with TipRanks
Follow Us
Yousha Neman-Ebrahim Insider Profile
4 Followers
Yousha Neman-Ebrahim, Chief Clinical Officer at NeOnc Technologies Holdings, Inc., holds 134.26K shares in NeOnc Technologies Holdings, Inc. (Ticker: NTHI). Most recently, Yousha Neman-Ebrahim Bought 1,100 shares of NeOnc Technologies Holdings, Inc. on Nov 24, 2025 for an estimated value of $7.36K.
Yousha Neman-Ebrahim has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Yousha Neman-Ebrahim's holdings
Insider Roles
Chief Clinical Officer
Roles that Yousha Neman-Ebrahim holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 24, 2025 - Today
Return:-4.20%
The most profitable trade made by Yousha Neman-Ebrahim
Yousha Neman-Ebrahim's Trading History
List of latest transactions for each holding click on a transaction to see Yousha Neman-Ebrahim's performance on stock
You May Also Like
Yousha Neman-Ebrahim insider profile FAQ
What is the percentage of profitable transactions made by Yousha Neman-Ebrahim?
The percentage of profitable transactions made by Yousha Neman-Ebrahim is ―.
What is the average return per transaction made by Yousha Neman-Ebrahim?
The average return per transaction made by Yousha Neman-Ebrahim is ―.
What stocks does Yousha Neman-Ebrahim hold?
Yousha Neman-Ebrahim holds: NTHI stocks.
What was Yousha Neman-Ebrahim’s latest transaction?
Yousha Neman-Ebrahim latest transaction was an Informative Buy of $7.36K.
What was Yousha Neman-Ebrahim's most profitable transaction?
Yousha Neman-Ebrahim’s most profitable transaction was an Informative Buy of NTHI stock on November 24, 2025. The return on the trade was -4.20%.
What is Yousha Neman-Ebrahim's role in NeOnc Technologies Holdings, Inc.?
Yousha Neman-Ebrahim's role in NeOnc Technologies Holdings, Inc. is Chief Clinical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.